Patten Group Inc. Grows Position in Halyard Health Inc (NYSE:HYH)

Patten Group Inc. raised its position in shares of Halyard Health Inc (NYSE:HYH) by 1,342.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 281,112 shares of the medical instruments supplier’s stock after purchasing an additional 261,626 shares during the period. Patten Group Inc. owned about 0.60% of Halyard Health worth $877,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Amalgamated Bank grew its stake in Halyard Health by 1.2% during the 2nd quarter. Amalgamated Bank now owns 6,655 shares of the medical instruments supplier’s stock worth $261,000 after buying an additional 82 shares during the last quarter. Texas Permanent School Fund lifted its position in Halyard Health by 0.8% during the 2nd quarter. Texas Permanent School Fund now owns 34,074 shares of the medical instruments supplier’s stock worth $1,338,000 after acquiring an additional 284 shares during the period. Arizona State Retirement System lifted its position in Halyard Health by 1.5% during the 2nd quarter. Arizona State Retirement System now owns 19,700 shares of the medical instruments supplier’s stock worth $774,000 after acquiring an additional 300 shares during the period. Capstone Asset Management Co. lifted its position in Halyard Health by 6.2% during the 2nd quarter. Capstone Asset Management Co. now owns 5,663 shares of the medical instruments supplier’s stock worth $222,000 after acquiring an additional 330 shares during the period. Finally, ETRADE Capital Management LLC lifted its holdings in shares of Halyard Health by 4.2% in the 2nd quarter. ETRADE Capital Management LLC now owns 9,671 shares of the medical instruments supplier’s stock valued at $380,000 after buying an additional 390 shares during the period. Institutional investors and hedge funds own 89.71% of the company’s stock.

Several equities analysts have recently issued reports on the company. TheStreet raised Halyard Health from a “c+” rating to a “b” rating in a report on Monday, December 4th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $52.00 price target on shares of Halyard Health in a report on Friday, November 3rd. ValuEngine upgraded Halyard Health from a “hold” rating to a “buy” rating in a research note on Sunday. Zacks Investment Research upgraded Halyard Health from a “hold” rating to a “buy” rating and set a $53.00 price target for the company in a research report on Wednesday, December 6th. Finally, KeyCorp restated a “hold” rating on shares of Halyard Health in a research report on Tuesday, October 17th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $46.25.

Shares of Halyard Health Inc (HYH) traded up $1.35 during midday trading on Tuesday, hitting $47.53. The stock had a trading volume of 310,807 shares, compared to its average volume of 249,250. The firm has a market capitalization of $2,230.00, a PE ratio of 39.94, a P/E/G ratio of 2.49 and a beta of 1.77. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.19 and a current ratio of 2.13. Halyard Health Inc has a twelve month low of $35.24 and a twelve month high of $50.99.

Halyard Health (NYSE:HYH) last posted its earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 EPS for the quarter, beating the consensus estimate of $0.47 by $0.13. The firm had revenue of $401.40 million for the quarter, compared to analyst estimates of $394.54 million. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. Halyard Health’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.48 earnings per share. sell-side analysts expect that Halyard Health Inc will post 2.08 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://www.truebluetribune.com/2018/01/03/patten-group-inc-raises-position-in-halyard-health-inc-hyh.html.

Halyard Health Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply